Phio Pharmaceuticals (PHIO) Interest & Investment Income (2011 - 2026)
Phio Pharmaceuticals' (PHIO) quarterly Interest & Investment Income came in at $161000.0 in Q1 2026, up 28.8% YoY from $125000.0 in Q1 2025, and up 91.67% on a QoQ basis from $84000.0 in Q4 2025.
Phio Pharmaceuticals (PHIO) Interest & Investment Income (2011 - 2026) Analysis & Trends
Phio Pharmaceuticals (PHIO) has 5 years of Interest & Investment Income data on file, last reported at $161000.0 in Q1 2026.
- Quarterly Interest & Investment Income rose 28.8% year-over-year to $161000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $465000.0 (up 176.79% YoY) and the FY2025 annual result came in at $84000.0, up 300.0% from the prior year.
- Interest & Investment Income climbed to $161000.0 in Q1 2026, from $84000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $161000.0 in Q1 2026 to a low of $21000.0 in Q4 2024.
- A 3-year average of $95000.0 and a median of $98500.0 in 2025 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2025 — Interest & Investment Income jumped 300.0% — and 2026, when it advanced 28.8%.
- Tracing PHIO's Interest & Investment Income over 3 years: stood at $21000.0 in 2024, then jumped by 300.0% to $84000.0 in 2025, then surged by 91.67% to $161000.0 in 2026.
- The last three Interest & Investment Income figures came in at $161000.0 (Q1 2026), $84000.0 (Q4 2025), and $113000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 28.14 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 10.98 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 5.13 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 115.94 Mn |
| 10 | Phio Pharmaceuticals | 14.06 Mn | 14.06 Mn | - | 130,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 130,000.00 |
| Mar 31, 2026 | 161,000.00 |
| Dec 31, 2025 | 84,000.00 |
| Sep 30, 2025 | 113,000.00 |
| Mar 31, 2025 | 125,000.00 |
| Dec 31, 2024 | 21,000.00 |
| Sep 30, 2024 | 66,000.00 |
| Mar 31, 2012 | -22,000.00 |
| Mar 31, 2011 | -1,000.00 |